The medical
peptide glossary.
A clinician-reviewed reference for every peptide, mechanism, biomarker, pharmacy term and regulatory concept in the Meto catalogue. Written to read like a colleague explaining it over coffee — not a textbook paste.
0-93 TERMS
5-Amino-1MQ
A small-molecule NNMT inhibitor that increases cellular NAD+ and β-hydroxybutyrate — investigational for metabolic health and fat-loss support.
Pharmacy & Regulation503A Pharmacy
A US compounding pharmacy that prepares medications for individual patients based on a specific prescription.
Mechanismβ3-AdrenoceptorBeta-3 Adrenergic Receptor
A receptor on fat cells whose activation triggers lipolysis — the target of peptides like AOD-9604.
A13 TERMS
Adiponectin
An adipokine with insulin-sensitising and anti-inflammatory effects — falls as visceral adiposity rises.
Clinical ConceptAdipose Tissue
Fat tissue — composed of adipocytes storing triglycerides, plus immune and vascular cells — the target of lipolytic peptides.
SafetyAdverse Event
Any unfavourable medical occurrence during treatment — reported to the clinician regardless of whether a direct link is suspected.
MechanismAgonist
A molecule that binds a receptor and triggers its activity — most therapeutic peptides are agonists of a specific endogenous receptor.
Clinical ConceptAmino Acid
The molecular building block of peptides and proteins — 20 standard amino acids link together via peptide bonds to form larger chains.
MechanismAMPKAMP-Activated Protein Kinase
The cellular energy sensor that triggers fat burning, glucose uptake and mitochondrial biogenesis when ATP runs low — activated by MOTS-c.
MechanismAmylin
A pancreatic peptide co-secreted with insulin that slows gastric emptying and reduces glucagon
MechanismAngiogenesis
The formation of new blood vessels from existing vasculature — the core repair mechanism BPC-157 accelerates via VEGF.
MechanismAntagonist
A molecule that binds a receptor and blocks its activation — used therapeutically to silence an over-active signalling pathway.
PeptideAOD-9604AOD9604
A modified fragment of human growth hormone (amino acids 177–191) that stimulates fat metabolism without affecting blood glucose or IGF-1.
Pharmacy & RegulationAPIActive Pharmaceutical Ingredient
The biologically active component of a medication — the specific peptide itself, before formulation.
BiomarkerApoBApolipoprotein B
The primary atherogenic protein in blood — a better cardiovascular-risk marker than LDL alone.
MechanismAutophagy
The cellular self-cleaning process that recycles damaged organelles and proteins — a core longevity mechanism activated by fasting, exercise and certain peptides.
B6 TERMS
Bacteriostatic Water
Sterile water with 0.9% benzyl alcohol preservative — the diluent used to reconstitute lyophilised peptide vials.
Delivery & DosingBioavailability
The fraction of a dose that reaches circulation in active form — a key reason most peptides are injected subcutaneously rather than taken orally.
BiomarkerBiomarker
A measurable substance in blood, tissue or urine that reflects a biological state — the inputs your clinician uses to choose the right protocol.
Clinical ConceptBMIBody Mass Index
A screening calculation (weight/height²) used to categorise body size — useful at population level, crude at the individual level.
PeptideBPC-157Body Protection Compound 157
A 15-amino-acid peptide derived from a protein in human gastric juice, studied for gut-lining repair and soft-tissue healing.
Pharmacy & RegulationBulks List
The FDA's list of substances permitted for compounding under Section 503A — the list that determines which peptides are legally compoundable.
C12 TERMS
CagriSema
A dual-peptide combination of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist) — investigational for weight management.
BiomarkerCBCComplete Blood Count
A foundational blood test measuring red cells, white cells, platelets and haemoglobin — used as a safety baseline before most peptide protocols.
PeptideCerebrolysin
A complex of neurotrophic peptides derived from porcine brain tissue — used clinically in Europe and Asia for stroke and cognitive-decline indications.
Pharmacy & RegulationcGMPCurrent Good Manufacturing Practice
FDA-enforced manufacturing standards for pharmaceutical products. 503A compounders operate under USP 795/797 standards rather than full cGMP.
Clinical ConceptCircadian Rhythm
The body's ~24-hour biological clock that governs sleep, hormone release and cellular repair
PeptideCJC-1295CJC-1295 no-DAC
A GHRH analog that extends the body's natural growth-hormone pulses — typically paired with Ipamorelin for muscle preservation and sleep quality.
BiomarkerCMPComprehensive Metabolic Panel
A 14-marker blood panel measuring glucose, electrolytes, kidney and liver function — standard safety work before most protocols.
Delivery & DosingCold Chain
Refrigerated shipping and storage throughout the supply chain — required for most lyophilised peptides to preserve potency.
MechanismCollagen Synthesis
The biological process of producing collagen — accelerated by peptides like GHK-Cu and BPC-157 during tissue repair.
Pharmacy & RegulationCompounded Peptide
A peptide prepared for an individual patient by a licensed compounding pharmacy, prescribed by a clinician and tested for identity, potency and contamination.
SafetyContraindication
A specific circumstance in which a medication should not be used — the list of 'if this, then no' conditions for each protocol.
Clinical ConceptCortisol
The body's primary stress hormone, secreted by the adrenals under HPA-axis control — one thing Ipamorelin specifically does not raise.
D6 TERMS
DEXA ScanDXA
A low-radiation scan that maps body composition into lean mass, fat mass and bone density — the clinical gold standard for tracking peptide outcomes.
BiomarkerDHEA-SDehydroepiandrosterone Sulfate
An adrenal steroid that declines steadily with age — a sensitive marker of adrenal-reserve capacity and biological-age metrics.
Delivery & DosingDose Titration
Gradually increasing a peptide dose from a low starting point — standard practice for GLP-1s, GHRH analogs and any protocol with GI or tolerance profiles.
SafetyDrug Interaction
An effect of one medication on the metabolism, absorption or action of another — why your clinician reviews your full medication list.
PeptideDSIPDelta Sleep-Inducing Peptide
A nine-amino-acid peptide studied for sleep architecture, particularly for deep (delta-wave) sleep restoration.
Clinical ConceptDyslipidemia
Abnormal blood lipid levels — elevated ApoB, LDL or triglycerides, or low HDL. A core cardiovascular-risk axis.
E4 TERMS
Endocrinology
The medical specialty concerned with hormones and the glands that secrete them — the parent discipline for peptide and metabolic medicine.
SafetyEndotoxin
A bacterial cell-wall fragment that can contaminate injectables — tested for in every batch of a compounded peptide.
PeptideEpitalonEpithalon
A four-amino-acid peptide that upregulates telomerase activity and restores pineal circadian signalling — typically cycled 10 days, quarterly.
BiomarkerEstradiolE2
The primary circulating estrogen — central to reproductive, bone, cardiovascular and cognitive health in both sexes.
F11 TERMS
Fasting Glucose
Blood glucose measured after an 8-hour fast — the simplest metabolic-safety screen before any GH-axis or GLP-1 protocol.
BiomarkerFasting Insulin
Insulin measured after an 8-hour fast — a sensitive early marker of insulin resistance.
Pharmacy & RegulationFDAFood and Drug Administration
The US regulatory body for drugs, devices and compounding pharmacies — the agency that classifies which peptides may be compounded.
BiomarkerFerritin
The body's iron storage protein — low values indicate depletion, high values often reflect inflammation rather than iron overload.
MechanismFirst-Pass Metabolism
The breakdown of an orally administered drug by the gut and liver before it reaches systemic circulation — the reason most peptides are injected.
PeptideFollistatinFollistatin 344
A naturally occurring protein that binds and inhibits myostatin — theoretically permitting greater muscle hypertrophy.
Clinical ConceptFood Noise
The intrusive mental chatter about food that GLP-1 receptor agonists quiet — a widely reported but underdocumented effect.
PeptideFragment 176-191HGH Frag 176-191
A fragment of human growth hormone (amino acids 176–191) with lipolytic activity — an older relative of AOD-9604.
Clinical ConceptFrailty
A clinical syndrome of reduced reserve and increased vulnerability — the downstream consequence of unchecked sarcopenia and age-related decline.
BiomarkerFree T3Free Triiodothyronine
The bioactive thyroid hormone — small changes have outsized clinical effects.
BiomarkerFree T4Free Thyroxine
The unbound, bioavailable fraction of thyroxine — the main circulating thyroid hormone.
G10 TERMS
Gastric Emptying
The rate at which food exits the stomach — slowed by GLP-1 receptor agonists, which extends satiety but can also cause nausea.
PeptideGHK-CuCopper Tripeptide-1
A naturally occurring copper-binding tripeptide that activates tissue-repair gene programs and collagen synthesis — used topically and injected.
MechanismGhrelin
The 'hunger hormone' secreted by the stomach — its receptor is the target of GH secretagogues like Ipamorelin.
MechanismGHRH AnalogGrowth-Hormone-Releasing Hormone Analog
A class of peptides that mimic growth-hormone-releasing hormone at the pituitary to trigger the body's own GH release — CJC-1295, Tesamorelin and Sermorelin.
PeptideGHRP-2
An older-generation GH secretagogue — active but less selective than Ipamorelin, rarely chosen in modern clinical protocols.
PeptideGHRP-6
Another older-generation GH secretagogue with strong appetite-stimulating activity — largely superseded by Ipamorelin in clinical use.
MechanismGIPGlucose-Dependent Insulinotropic Polypeptide
An incretin hormone released by gut K-cells after a meal — the second receptor targeted by tirzepatide, on top of GLP-1.
PeptideGLP-1 Receptor AgonistGLP-1 RA
A peptide drug class that mimics glucagon-like peptide-1 to slow gastric emptying, sharpen insulin response and quiet food-noise.
PeptideGonadorelinGnRH analog
A synthetic analog of gonadotropin-releasing hormone — used to support testicular function during TRT or fertility protocols.
MechanismGrowth HormoneGH
A pituitary-secreted hormone that drives protein synthesis, fat metabolism and tissue repair — released in pulses, peaking at night.
H10 TERMS
Half-Lifet½
The time required for a drug's plasma concentration to drop by half — a key determinant of dosing frequency.
BiomarkerHbA1cGlycated Haemoglobin
A blood marker of average glucose over the prior 3 months — the standard metric for diabetes screening and GH-axis protocol safety.
BiomarkerHDL CholesterolHigh-Density Lipoprotein
The cholesterol carried on high-density lipoproteins — associated with cardiovascular protection but no longer directly targetable.
PeptideHexarelin
A potent GH secretagogue — more powerful than Ipamorelin but with less selectivity, so less often chosen in modern protocols.
BiomarkerHOMA-IRHomeostatic Model Assessment of Insulin Resistance
A calculated insulin-resistance score from fasting glucose and fasting insulin — a sensitive early metabolic-dysfunction marker.
BiomarkerHomocysteine
An amino-acid metabolite — elevated values indicate B-vitamin deficiency and are an independent cardiovascular risk marker.
Clinical ConceptHPA AxisHypothalamic-Pituitary-Adrenal Axis
The feedback loop between hypothalamus, pituitary and adrenals that governs cortisol and stress response.
Biomarkerhs-CRPHigh-Sensitivity C-Reactive Protein
A sensitive inflammation marker — elevated values change which peptides a clinician selects and at what dose.
Clinical ConceptHypertension
Persistently elevated blood pressure — 130/80 mmHg and above by current US guidelines.
Clinical ConceptHypothalamus
The brain region that integrates endocrine, autonomic and behavioural signals — the command centre of the HPA, HPG and HP-thyroid axes.
I10 TERMS
IGF-1Insulin-like Growth Factor 1
The primary blood marker of growth-hormone activity — the lab that gates any GH-axis protocol and the one re-checked at month 3.
PeptideIGF-1 LR3Long R3 IGF-1
A modified, long-acting variant of IGF-1 with reduced binding-protein affinity — potent but with a serious safety profile for most use-cases.
MechanismIncretin
A gut hormone released after a meal that amplifies insulin secretion — the hormonal family targeted by semaglutide and tirzepatide.
Clinical ConceptInflammation
The body's protective response to injury or infection — helpful acutely, destructive when chronic, and a major target of several peptides.
Delivery & DosingInjection Site Rotation
The practice of varying subcutaneous injection location across sessions to prevent lipoatrophy and injection-site reactions.
Clinical ConceptInsulin Sensitivity
How effectively cells respond to insulin — improved by exercise, GLP-1s, MOTS-c and most metabolic peptides.
Delivery & DosingInsulin Syringe
The 30–31-gauge syringe calibrated in insulin units — the standard tool for subcutaneous peptide self-injection.
Delivery & DosingIntramuscular InjectionIM Injection
Injection into muscle tissue — faster absorption than subcutaneous, used for specific peptides and hormone therapies.
Delivery & DosingIntranasal Administration
Delivery via the nasal mucosa — used for peptides like Selank, Semax and certain oxytocin protocols where CNS access matters.
PeptideIpamorelin
A selective growth-hormone secretagogue that triggers GH release without spiking cortisol or prolactin — usually paired with CJC-1295.
K2 TERMS
L9 TERMS
LDL CholesterolLow-Density Lipoprotein
The cholesterol carried on low-density lipoproteins — the traditional cardiovascular-risk marker, increasingly supplemented by ApoB.
MechanismLeptin
A hormone secreted by fat cells that signals energy stores to the brain — dysfunctional in most obesity and blunted by chronic inflammation.
MechanismLeptin Resistance
The state in which elevated leptin levels fail to suppress appetite — a core mechanism of obesity and metabolic syndrome.
MechanismLipolysis
The biological breakdown of stored fat into free fatty acids — the mechanism targeted by AOD-9604 and Tesamorelin.
PeptideLiraglutideSaxenda
A once-daily GLP-1 receptor agonist — the older-generation alternative to semaglutide, with a shorter half-life and daily dosing.
BiomarkerLiver Function TestsLFTs
Blood tests measuring hepatic enzymes (ALT, AST, ALP) and bilirubin — reviewed before starting protocols with liver exposure.
PeptideLL-37Cathelicidin
A naturally occurring human antimicrobial peptide with broad-spectrum activity and immune-modulating effects.
Clinical ConceptLongevity
The domain of medicine focused on healthspan and the biology of aging — the central interest behind NAD+, Epitalon and MOTS-c.
Delivery & DosingLyophilisationFreeze-Drying
The freeze-drying process used to stabilise peptides for shipping — the vial you reconstitute with bacteriostatic water on arrival.
M7 TERMS
Melanotan IIMT-II
A melanocortin agonist originally studied for skin pigmentation as a photoprotective agent — not part of the Meto catalogue for safety reasons.
Clinical ConceptMelatonin
The hormone secreted by the pineal gland at night that regulates sleep-wake timing — downstream of circadian-active peptides.
Clinical ConceptMetabolic Syndrome
A cluster of five conditions — central obesity, hypertension, dyslipidaemia, hyperglycaemia, low HDL — that together multiply cardiovascular risk.
PeptideMGFMechano Growth Factor
A splice variant of IGF-1 released by mechanically stressed muscle — studied for satellite-cell activation and localised muscle repair.
Clinical ConceptMitochondria
The cellular organelles that produce ATP — the direct target of NAD+ supplementation and mitochondrial peptides like MOTS-c.
PeptideMOTS-cMitochondrial Open Reading Frame of 12S rRNA type-c
A 16-amino-acid peptide encoded in mitochondrial DNA that improves insulin sensitivity and cellular energy output.
MechanismmTORMechanistic Target of Rapamycin
A master growth-signalling kinase that integrates nutrient, energy and hormonal cues — the counterweight to autophagy in longevity biology.
N3 TERMS
NAD+Nicotinamide Adenine Dinucleotide
A co-enzyme every cell uses to make energy. Levels drop ~50% by age 60; injected NAD+ restores the baseline.
Clinical ConceptNAFLD / MASLDNon-alcoholic Fatty Liver Disease
Fat accumulation in the liver driven by metabolic dysfunction — renamed MASLD in 2023 to reflect the central role of metabolism.
MechanismNitric OxideNO
A signalling molecule that regulates blood flow and tissue repair — modulated by BPC-157 at the gut lining and injury sites.
O2 TERMS
Oral Bioavailability
The fraction of an orally taken drug that survives digestion and reaches circulation — typically under 1% for peptides.
PeptideOxytocin
A naturally occurring nine-amino-acid peptide hormone that governs social bonding, childbirth and lactation — used clinically in specific compounded contexts.
P9 TERMS
Peptide
A short chain of amino acids — longer than a single amino acid, shorter than a full protein — that acts as a precise biological signal.
Clinical ConceptPeptide Bond
The covalent link between two amino acids — the chemistry that defines every peptide and protein.
BiomarkerPeptide Readiness Panel
Meto's $149 lab panel covering the biomarkers needed to match a patient to the right peptide protocol safely.
MechanismPharmacodynamicsPD
What a drug does to the body — the receptor binding and downstream signalling that produce the clinical effect.
MechanismPharmacokineticsPK
What the body does to a drug — absorption, distribution, metabolism and excretion. The science of dose-to-plasma-level relationships.
Clinical ConceptPineal Gland
A small endocrine gland in the brain that secretes melatonin — the anatomical origin of Epitalon's developmental story.
Clinical ConceptPituitary Gland
The 'master gland' at the base of the brain that secretes growth hormone, ACTH, TSH and other downstream hormones.
Clinical ConceptPrediabetes
Elevated blood glucose below the diabetic threshold — HbA1c 5.7-6.4% or fasting glucose 100-125 mg/dL. Reversible with lifestyle or medication.
PeptidePT-141Bremelanotide
A melanocortin-receptor agonist used for sexual-function support — FDA-approved as Vyleesi for acquired hypoactive sexual desire disorder in women.
R4 TERMS
Receptor Binding
The molecular interaction between a drug and its receptor — the first step in pharmacodynamics and the determinant of specificity.
Delivery & DosingReconstitution
Mixing bacteriostatic water into a freeze-dried peptide vial to create a usable solution — the step every member does on arrival.
SafetyResearch Chemical
Unregulated peptides sold online labelled 'not for human use' — not a legitimate prescription pathway and not tested for patient safety.
PeptideRetatrutide
A next-generation triple agonist targeting GLP-1, GIP and glucagon receptors — the most effective weight-management peptide seen in phase-2 trials.
S13 TERMS
Sarcopenia
Age-related loss of muscle mass and function — the silent metabolic disease that undermines most other longevity efforts.
PeptideSelank
A synthetic neuropeptide with anxiolytic and pro-cognitive effects — administered intranasally or as oral drops.
PeptideSemaglutideOzempic
A long-acting GLP-1 receptor agonist used for type-2 diabetes and chronic weight management — the active ingredient in Ozempic and Wegovy.
PeptideSemax
A Russian-developed cognitive peptide used clinically for stroke recovery and ADHD — a BDNF-potentiating nootropic with an anxiolytic edge.
MechanismSenescence
The cellular state of permanent growth arrest with secretion of pro-inflammatory signals — a central driver of biological aging.
MechanismSenolytic
A class of therapies that selectively eliminate senescent cells — an emerging longevity approach, mostly small-molecule rather than peptide.
PeptideSermorelin
A native GHRH analog — the gentlest and most-studied entry point into growth-hormone-axis therapy.
BiomarkerSHBGSex Hormone-Binding Globulin
A hepatic protein that binds testosterone and estradiol — affects how much hormone is bioavailable and how lab values are interpreted.
MechanismSirtuins
A family of NAD+-dependent enzymes that regulate metabolism, stress response and aging
Clinical ConceptSleep Architecture
The pattern of sleep stages across the night — deep sleep, REM and light sleep cycles.
MechanismSomatostatin
A hypothalamic peptide that inhibits growth-hormone release — the brake that balances the GHRH accelerator.
PeptideSS-31Elamipretide
A mitochondria-targeted peptide that stabilises cardiolipin and restores mitochondrial function in stressed cells.
Delivery & DosingSubcutaneous InjectionSQ Injection
Injection into the fatty layer just below the skin — the standard route for peptide dosing, self-administered with an insulin syringe.
T13 TERMS
TB-500Thymosin Beta-4
A synthetic fragment of Thymosin-β4 that accelerates cellular migration to damaged tissue — the recovery-focused partner to BPC-157.
Pharmacy & RegulationTelehealth Prescribing
Prescription of a medication after a virtual clinician encounter — the legal framework under which Meto operates.
MechanismTelomerase
The enzyme that maintains telomere length at chromosome ends — upregulated by Epitalon in longevity cycles.
Clinical ConceptTelomere
The protective DNA cap at the end of each chromosome — shortens with age and each cell division.
PeptideTesamorelin
A stabilised GHRH analog with FDA approval for visceral-fat reduction in HIV-associated lipodystrophy — increasingly used off-label for metabolic syndrome.
BiomarkerTestosterone
The primary male androgen — measured as total and free fractions. Low levels in men drive the TRT decision; in women, context is everything.
PeptideThymosin α-1Thymalfasin
A 28-amino-acid peptide produced by the thymus that modulates T-cell balance and NK-cell activity — used clinically in 30+ countries.
PeptideThymosin β-4Tβ4
The parent peptide behind TB-500 — a 44-amino-acid naturally occurring actin-regulating peptide studied for systemic repair.
Clinical ConceptThyroid AxisHypothalamic-Pituitary-Thyroid Axis
The feedback loop between hypothalamus (TRH), pituitary (TSH) and thyroid (T4, T3) — governs metabolic rate across tissues.
PeptideTirzepatideMounjaro
A dual GLP-1 and GIP receptor agonist — the most effective FDA-approved weight-management peptide to date, the active ingredient in Mounjaro and Zepbound.
Delivery & DosingTitration
See Dose Titration — the staged escalation of a peptide dose from a low starting point to the target therapeutic dose.
BiomarkerTriglycerides
Blood fats that reflect dietary and metabolic patterns — elevated values are a sensitive early marker of insulin resistance.
BiomarkerTSHThyroid-Stimulating Hormone
The pituitary hormone that drives thyroid output — the primary screening test for thyroid function.
V3 TERMS
VEGFVascular Endothelial Growth Factor
A signalling protein that drives the growth of new blood vessels — the primary mechanism behind BPC-157's tissue-repair effects.
Clinical ConceptVisceral FatVisceral Adipose Tissue
Fat stored around internal organs — metabolically active, tied to cardiovascular risk, and the target of Tesamorelin and SCULPT.
BiomarkerVitamin D25-hydroxy Vitamin D
A fat-soluble vitamin that functions more like a hormone — widely deficient, with broad effects on immune, bone and metabolic health.
W3 TERMS
WADAWorld Anti-Doping Agency
The body whose prohibited list includes BPC-157, TB-500, GHRH analogs and most growth-hormone-axis peptides.
Clinical ConceptWellness Score
A composite metric built from member-tracked symptoms, lab trends and functional measures — Meto's internal measure of protocol response.
Clinical ConceptWound Healing
The four-phase biological process that repairs tissue damage — haemostasis, inflammation, proliferation and remodelling.
Skip the guesswork.
Start with labs.
A $149 metabolic panel. A clinician-reviewed protocol within 24 hours. No one peptide is right for everyone — your labs and goals point to the stack that fits your biology.